Published in J Virol on May 01, 1969
Specific endonuclease R fragments of bacteriophage phiX174 deoxyribonucleic acid. J Virol (1972) 5.98
Mapping of new Escherichia coli K and 15 restriction sites on specific fragments of bacteriophage phi X174. J Virol (1973) 1.52
Recognition site of Escherichia coli B restriction enzyme on phi XsB1 and simian virus 40 DNAs: an interrupted sequence. Proc Natl Acad Sci U S A (1978) 1.51
Nucleotide sequence of the recognition site for the restriction-modification enzyme of Escherichia coli B. Proc Natl Acad Sci U S A (1978) 1.28
Gene K of bacteriophage phi X174 codes for a protein which affects the burst size of phage production. J Virol (1985) 0.83
Construction and properties of a ribosome-binding site mutation in gene E of phi X174 bacteriophage. J Virol (1984) 0.83
Host specificity of DNA produced by Escherichia coli: bacterial mutations affecting the restriction and modification of DNA. J Mol Biol (1966) 12.77
Host specificity of DNA produced by Escherichia coli. 9. Host-controlled modification of bacteriophage fd. J Mol Biol (1966) 2.80
[Mutational loss of the B-specific restriction in bacteriophage fd]. Pathol Microbiol (Basel) (1967) 2.04
Susceptibility of different coliphage genomes to host-controlled variation. J Bacteriol (1967) 1.64
Restriction of infectious bacteriophage fd DNA's and an assay for in vitro host-controlled restriction and modification. Proc Natl Acad Sci U S A (1968) 1.39
Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J (1982) 17.98
Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature (1993) 3.88
Inhibition of minicircular DNA replication in Escherichia coli 15 by rifampicin. Nat New Biol (1972) 3.10
The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science (1994) 3.07
Expression in Escherichia coli of hepatitis B virus DNA sequences cloned in plasmid pBR322. Nature (1979) 3.03
Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. Proc Natl Acad Sci U S A (1985) 2.67
Isolation and characterization of a ribonuclease 3 deficient mutant of Escherichia coli. Mol Gen Genet (1973) 2.19
Cloning of cDNA of major antigen of foot and mouth disease virus and expression in E. coli. Nature (1981) 2.14
In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A (1987) 2.05
The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis. Oncogene (1988) 2.02
Integration of hepatitis B virus DNA: evidence for integration in the single-stranded gap. Cell (1983) 1.87
Liposomes as gene carriers: efficient transformation of mouse L cells by thymidine kinase gene. Science (1982) 1.78
The preS2/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator. Nature (1990) 1.69
Uber infektiöse Substrukturen aus Escherichia coli Bakteriophagen. VII. Formation of a biologically intact replicative form in ribonucleic acid bacteriophage (M12)-infected cells. J Mol Biol (1966) 1.63
Appearance of beta-lactamase activity in animal cells upon liposome-mediated gene transfer. Gene (1980) 1.63
Infectious nucleic acids of e. Coli bacteriophages, ix. Sedimentation constants and strand integrity of infectious m12 phage replicative-form RNA. Proc Natl Acad Sci U S A (1966) 1.58
Diversity of surface layers in L-forms of Proteus mirabilis. J Gen Microbiol (1968) 1.57
A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene (1988) 1.54
Translation of avian myeloblastosis virus RNA in a cell-free lysate of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.53
Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J Mol Cell Cardiol (1985) 1.52
Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci U S A (1992) 1.47
Purification, renaturation, and reconstituted protein kinase activity of the Sendai virus large (L) protein: L protein phosphorylates the NP and P proteins in vitro. J Virol (1990) 1.46
Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization. EMBO J (1992) 1.43
Infectious nucleic acids of Escherichia coli bacteriophages. 10. Preparation and properties of Escherichia coli competent for infectious DNA from bacteriophages phi X 174 and M 13 and RNA from bacteriophage M 12. Eur J Biochem (1967) 1.37
The hepatitis B virus large surface protein (LHBs) is a transcriptional activator. Virology (1996) 1.32
Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene (1995) 1.29
Large-scale preparations of viruses by steric chromatography on columns of controlled pore glass. Phi-X174, M13, M12, Q-beta and T4 bacteriophages. Biochim Biophys Acta (1969) 1.29
A trans-activator function is generated by integration of hepatitis B virus preS/S sequences in human hepatocellular carcinoma DNA. Proc Natl Acad Sci U S A (1990) 1.27
Detection of hepatitis B virus-specific DNA in the genomes of human hepatocellular carcinoma and liver cirrhosis tissues. J Gen Virol (1981) 1.26
Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses. J Virol (1995) 1.26
Sendai virus gene expression in lytically and persistently infected cells. Virology (1990) 1.24
Gene order of RNA bacteriophage M 12. Nature (1970) 1.24
Deoxyribonucleic acid-envelope complexes isolated from Escherichia coli by free-flow electrophoresis: biochemical and electron microscope characterization. J Bacteriol (1974) 1.24
Keratinocyte growth factor is highly overexpressed in inflammatory bowel disease. Am J Pathol (1996) 1.21
Expression of hepatitis B surface antigen in unselected cell culture transfected with recircularized HBV DNA. EMBO J (1982) 1.21
Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides. Hepatology (1995) 1.17
Biologically active protease of foot and mouth disease virus is expressed from cloned viral cDNA in Escherichia coli. Proc Natl Acad Sci U S A (1984) 1.16
An RNA-dependent DNA polymerase, different from the known viral reverse transcriptases, in the chicken system. Proc Natl Acad Sci U S A (1976) 1.15
Viral heart disease. Springer Semin Immunopathol (1989) 1.13
The HBV-producing cell line HepG2-4A5: a new in vitro system for studying the regulation of HBV replication and for screening anti-hepatitis B virus drugs. Virology (1996) 1.11
Secondary structure of RNA phage M12 replicative intermediates in vivo. Biochim Biophys Acta (1973) 1.10
Enhanced production of hepatitis B surface antigen in NIH 3T3 mouse fibroblasts by using extrachromosomally replicating bovine papillomavirus vector. Mol Cell Biol (1983) 1.09
Lysis inhibition of phi-X174-, M12-, and Q-beta-infected Escherichia coli bacteria by magnesium ions. Biochim Biophys Acta (1969) 1.08
Interference of bacteriophage T4 in the reproduction of RNA-phage M12. J Mol Biol (1967) 1.07
Strand-specific detection of enteroviral RNA in myocardial tissue by in situ hybridization. Mol Cell Probes (1991) 1.07
The genetic organization of integrated hepatitis B virus DNA in the human hepatoma cell line PLC/PRF/5. Nucleic Acids Res (1984) 1.06
Amplification and rearrangement in hepatoma cell DNA associated with integrated hepatitis B virus DNA. EMBO J (1984) 1.06
Detection of parvovirus in a patient with "reactive arthritis" by in situ hybridization. Clin Rheumatol (1989) 1.06
Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene (1994) 1.06
Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera. DNA (1988) 1.05
Membrane attachment of replicating parental DNA molecules of bacteriophage M13. Biochem Biophys Res Commun (1971) 1.05
Replication of bacteriophage M 13: inhibition of single-strand DNA synthesis by rifampicin. Proc Natl Acad Sci U S A (1972) 1.03
Characterization of essential domains for the functionality of the MHBst transcriptional activator and identification of a minimal MHBst activator. Oncogene (1995) 1.02
Recombinant retroviral DNA yielding high expression of hepatitis B surface antigen. EMBO J (1982) 0.99
Hepatoma-derived integrated HBV DNA causes multi-stage transformation in vitro. Oncogene (1996) 0.99
The PreS2 activators of the hepatitis B virus: activators of tumour promoter pathways. Recent Results Cancer Res (1998) 0.99
Type I interferons inhibit hepatitis B virus replication and induce hepatocellular gene expression in cultured liver cells. J Infect Dis (1992) 0.99
Isolation and molecular characterization of hepatitis B virus X-protein from a baculovirus expression system. Hepatology (1997) 0.99
Shock wave permeabilization as a new gene transfer method. Gene Ther (1997) 0.98
Direct evidence for messenger activity of influenza virion RNA. Proc Natl Acad Sci U S A (1973) 0.97
Cultured, AIDS-related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitro. Int J Cancer (1988) 0.96
Replication of the single stranded DNA bacteriophage M 13. Intracellular flow of parental DNA and transfer to progeny particles. Eur J Biochem (1970) 0.96
Replication of bacteriophage M13: specificity of the Escherichia coli dnaB function for replication of double-stranded M13 DNA. Proc Natl Acad Sci U S A (1972) 0.95
Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma. Rheumatol Int (1987) 0.95
Cultured Kaposi's sarcoma-derived cells express functional PDGF A-type and B-type receptors. Exp Cell Res (1990) 0.95
Isolation of an infectious RNA-A-protein complex from the bacteriophage M12. FEBS Lett (1975) 0.95
Controlled release of particle-associated RNA-dependent DNA polymerase by primary chick embryo cell cultures. Exp Cell Res (1978) 0.94
Influence of T4 on the formation of RNA phage-specific polyribosomes and polymerase. J Mol Biol (1968) 0.94
Replication of the small coliphage M13: evidence for long-living M13 specific messenger RNA. Nature (1970) 0.93
Depletion of PDGF from serum inhibits growth of AIDS-related and sporadic Kaposi's sarcoma cells in culture. Oncogene (1989) 0.93
Co-transcribed 3' host sequences augment expression of integrated hepatitis B virus DNA. EMBO J (1985) 0.92
[Interferon in chronic polyarthritis. Positive effect in clinical evaluation]. Dtsch Med Wochenschr (1985) 0.92
Cells derived from sporadic and AIDS-related Kaposi's sarcoma reveal identical cytochemical and molecular properties in vitro. Int J Cancer (1989) 0.92
Characterization of the N-terminal part of the neutralizing antigenic site I of coxsackievirus B4 by mutation analysis of antigen chimeras. Virus Res (1994) 0.92
The hepatitis B virus pre-S/S(t) transactivator is generated by 3' truncations within a defined region of the S gene. J Virol (1992) 0.92
Coat protein repression of bacteriophage M12 RNA directed polysome formation. Eur J Biochem (1970) 0.92
Demonstration of free reverse transcriptase in the nuclei of embryonic tissues of the Japanese quail. Biochem Biophys Res Commun (1983) 0.91
Replication of the single-stranded DNA bacteriophage M13: absence of intracellular phages. J Mol Biol (1970) 0.91
Synergistic interaction of interferon-beta and interferon-gamma in coxsackievirus B3-infected carrier cultures of human myocardial fibroblasts. J Infect Dis (1992) 0.91
Replication of the single-stranded DNA bacteriophage M13: messenger RNA synthesis directed by M13 replicative form DNA. J Mol Biol (1969) 0.90
Endonuclease activity associated with the DNA protein complex of minicircular DNA of Escherichia coli 15. Eur J Biochem (1973) 0.89
Core specific antisense phosphorothioate oligodeoxynucleotides as potent and specific inhibitors of hepatitis C viral translation. Arch Virol (1997) 0.89
Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic mice. Circ Res (1993) 0.89
The hepatitis B virus MHBst167 protein is a pleiotropic transactivator mediating its effect via ubiquitous cellular transcription factors. J Gen Virol (1997) 0.88
Replication of bacteriophage M 13. Mechanism of single-strand DNA synthesis in an escherichia coli mutant thermosensitive in chromosomal DNA replication. Eur J Biochem (1972) 0.88
Analysis of bacteriophage-M 13-DNA replication in an Escherichia coli mutant thermosensitive in DNA polymerase 3. Eur J Biochem (1973) 0.88
Isolation and characterization of retrovirus-like elements from normal human fetuses. Int J Cancer (1982) 0.88
Isolation of circular DNA by zonal centrifugation. Separation of normallength, double length and catenated M13 replicative form DNA and of host specific "episomal" DNA. Biochim Biophys Acta (1969) 0.87
Lifelong persistence of paramyxovirus Sendai-6/94 in C129 mice: detection of a latent viral RNA by hybridization with a cloned genomic cDNA probe. Virology (1984) 0.87
Isolation of highly purified, functional carboxy-terminally truncated hepatitis B virus middle surface protein activators from eucaryotic expression systems. Hepatology (1996) 0.87
Search for Sendai 6/94 viral RNA in the antigen-free cell line Cl-C-2 isolated from human multiple sclerosis brain tissue. Infect Immun (1983) 0.86
Replication of bacteriophage M-13. Positive role of gene-5 protein in single-strand-DNA synthesis. Eur J Biochem (1973) 0.86
Anti-hepatitis B virus activity of N-acetyl-L-cysteine (NAC): new aspects of a well-established drug. Antiviral Res (1996) 0.85
Replication of bacteriophage M13 DNA in plasmolysed Escherichia coli cells. Biochem Biophys Res Commun (1973) 0.85
Purification and characterization of particles containing RNA-dependent DNA polymerase, in the allantoic fluid of uninfected leukosis virus-free chicken eggs. Biochim Biophys Acta (1978) 0.85
Low-dose gamma interferon in treatment of rheumatoid arthritis. Lancet (1988) 0.84
ER-localization and functional expression of the HBV transactivator MHBst. Oncogene (1993) 0.84
The hepatitis B virus transactivator HBx causes elevation of diacylglycerol and activation of protein kinase C. Res Virol (1993) 0.84
Replication of the single-stranded DNA bacteriophage M 13. On the transcription in vivo of the M 13 replicative-form DNA. Eur J Biochem (1973) 0.84
The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation. Hepatology (1994) 0.82